Nevada Administrative Code
Chapter 631 - Dentistry and Dental Hygiene
MISCELLANEOUS PROVISIONS
Section 631.258 - Administration of certain neuromodulators related to Clostridium botulinum and dermal or soft tissue fillers: Restrictions on use

Universal Citation: NV Admin Code 631.258

Current through September 16, 2024

1. A dentist who is authorized, pursuant to NRS 454.217, to inject a neuromodulator that is derived from Clostridium botulinum or that is biosimilar to or the bioequivalent of such a neuromodulator or who is authorized, pursuant to NRS 629.086, to inject a dermal or soft tissue filler, and who has satisfied the requirements of NAC 631.257 shall not:

(a) Administer such an injection to a person other than a patient of record; or

(b) Inject such a neuromodulator or filler at an injection site that is outside the oral cavity, maxillofacial area or the adjacent and associated structures of the person.

2. As used in this section, "patient of record" means a person for whom the dentist has, not more than 18 months before the injection of a neuromodulator or filler described in subsection 1:

(a) Performed a clinical examination;

(b) Completed or evaluated a medical and dental history;

(c) Diagnosed an oral condition; and

(d) Developed a written plan of treatment.

Added to NAC by Bd. of Dental Exam'rs by R044-17AP, eff. 5/16/2018

NRS 631.190

Disclaimer: These regulations may not be the most recent version. Nevada may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.